Eosinophilic cystitis: three cases, and a review over 10 years
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Eosinophilic cystitis : three cases, and a review over 10 years. / Mosholt, Karina Sif Søndergaard; Dahl, Claus; Azawi, Nessn Htum.
In: BMJ Case Reports, Vol. 2014, 2014.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Eosinophilic cystitis
T2 - three cases, and a review over 10 years
AU - Mosholt, Karina Sif Søndergaard
AU - Dahl, Claus
AU - Azawi, Nessn Htum
N1 - 2014 BMJ Publishing Group Ltd.
PY - 2014
Y1 - 2014
N2 - Eosinophilic cystitis (EC) is a rare disease. We describe three cases, where presentations of the disease are similar. To highlight probable causes of the disease, symptoms, clinical findings and treatment modalities, we reviewed 56 cases over a 10-year period. The most common symptoms were frequency, dysuria, urgency, pain and haematuria. Common clinical findings were presence of bladder mass, peripheral eosinophilia and thickened bladder wall. A variety of medical treatments were used, most frequently steroids, antibiotics and antihistamines. Recurrence occurred in patients on tapering or discontinuing prednisone, among other reasons. There is no consensus about the treatment of EC, but In light of our findings in this review, the treatment of choice in our department will be tapered prednisone over 6-8 weeks in combination with antihistamine.
AB - Eosinophilic cystitis (EC) is a rare disease. We describe three cases, where presentations of the disease are similar. To highlight probable causes of the disease, symptoms, clinical findings and treatment modalities, we reviewed 56 cases over a 10-year period. The most common symptoms were frequency, dysuria, urgency, pain and haematuria. Common clinical findings were presence of bladder mass, peripheral eosinophilia and thickened bladder wall. A variety of medical treatments were used, most frequently steroids, antibiotics and antihistamines. Recurrence occurred in patients on tapering or discontinuing prednisone, among other reasons. There is no consensus about the treatment of EC, but In light of our findings in this review, the treatment of choice in our department will be tapered prednisone over 6-8 weeks in combination with antihistamine.
U2 - 10.1136/bcr-2014-205708
DO - 10.1136/bcr-2014-205708
M3 - Journal article
C2 - 25312971
VL - 2014
JO - BMJ Case Reports
JF - BMJ Case Reports
SN - 1757-790X
ER -
ID: 135453420